- Home
- QFIN vs STAA Comparison
QFIN vs STAA Comparison
Compare QFIN & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | QFIN | STAA |
|---|---|---|
| Founded | 2016 | 1982 |
| Country | China | United States |
| Employees | N/A | 957 |
| Industry | Finance: Consumer Services | Ophthalmic Goods |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | 2018 | 1995 |
Fundamental Metrics
Financial Performance| Metric | QFIN | STAA |
|---|---|---|
| Price | $8.49 | $22.65 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 9 |
| Target Price | $22.20 | ★ $22.81 |
| AVG Volume (30 Days) | ★ 2.9M | 874.6K |
| Earning Date | 05-18-2026 | 05-12-2026 |
| Dividend Yield | ★ 12.36% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.26 |
| Revenue | N/A | ★ $239,442,000.00 |
| Revenue This Year | N/A | $30.82 |
| Revenue Next Year | N/A | $8.41 |
| P/E Ratio | ★ $2.21 | $90.85 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.35 | $15.59 |
| 52 Week High | $32.69 | $35.87 |
Technical Indicators
Market Signals| Indicator | QFIN | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 24.46 | 47.81 |
| Support Level | $8.35 | $23.27 |
| Resistance Level | $14.28 | $24.26 |
| Average True Range (ATR) | 0.47 | 0.82 |
| MACD | -0.04 | 0.17 |
| Stochastic Oscillator | 3.58 | 70.13 |
Price Performance
Historical ComparisonAbout QFIN Qifu Technology Inc.
Qfin Holdings Inc is engaged in matching individual borrowers with credit demand to a diversified pool of financial institutions with credit to supply through a financial technology platform. It has released large-scale financial credit multimodal benchmark, building a critical bridge between credit AI research and real-world applications.
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.